RecallDepth
Class III Terminated

Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial. Intravenous, Intramuscular, Subcutaneous Use, Rx Only, Hospira, Inc., Lake Forest IL USA, NDC 0406-2336-10.

Company
Pfizer Inc.
Recall Initiated
July 12, 2017
Posted
October 11, 2017
Recall Number
D-0001-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
32,276 10 mL vials
Firm Location
New York, NY, United States

Reason for Recall

CGMP Deviations: Firm failed to control impurity for color change at the API stage.

Distribution

Nationwide

Lot / Code Info

Lot: 51275DD; Exp. 09/01/17

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class III Drug recalls